冠状动脉微血管功能障碍患者心律不整的发生率
Kalyan R Chitturi1, Sant Kumar2, Andrew P Hill1
1Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
概括
冠状动脉微血管功能障碍 (CMD) 患有心痛和非阻塞性冠状动脉 (ANOCA) 患者的冠状动脉功能障碍与心律失常的更高患病率有关,特别是心室心律失常. 这一发现强调了微血管健康和心脏电稳定性之间的显著联系.
科学领域:
- 心脏病学 心脏病学
- 心脏电生理学 心脏电生理学
- 血管医学 血管医学
背景情况:
- 冠状动脉微血管功能障碍 (CMD) 是带有非阻塞性冠状动脉 (ANOCA) 的胸痛的主要原因.
- 对于CMD和心律失常的发生之间的关系仍然不完全理解.
- 研究这种关联对于理解ANOCA病理生理学至关重要.
研究的目的:
- 为了确定被诊断为ANOCA和CMD的患者心律失常的流行率.
- 为了比较ANOCA患者的心律失常率,有CMD与没有CMD的患者相比.
- 在这个人群中确定与CMD相关的特定类型的心律失常.
主要方法:
- 使用冠状动脉微血管疾病注册表 (NCT05960474) 的数据进行的观察性研究.
- 纳入标准:患有ANOCA的患者接受CMD侵入性冠状动脉功能评估.
- 心律失常的诊断通过12导电图或通过ECG证据的临床诊断在CMD评估前一年内得到证实.
主要成果:
- 这项研究包括262名患者;66人 (25.2%) 患有CMD.
- 患有CMD的患者表现出明显更高的早收缩率 (PACs),中心膜上高心率 (SVT),早复合体 (PVCs) 和不持续的中心膜高心率 (NSVT).
- 多变量分析证实CMD是PAC,SVT,PVC和NSVT的独立预测因素.
结论:
- 患有ANOCA和同时存在的CMD的患者表现出患心律失常的风险增加.
- 腹腔心律不整,包括PVC和NSVT,在这个患者群中尤其普遍.
- 这些发现强调了在评估ANOCA患者心律失常时考虑微血管功能的重要性.
相关概念视频
Mechanism of Cardiac Arrhythmias
889
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
889
Disturbances in Heart Rhythm
904
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
904
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
191
Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
191
Pathophysiology of Cardiac Performance
557
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
557
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
707
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
707
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K


